Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.| The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Tec...
JUPITER, Fla. — A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain cancer newly…| ufhealth.org
Related News Using AI, USC researchers pioneer a potential new immunotherapy approach for treating glioblastoma August 1, 2024 An early blood test can predict survival in patients with metastatic prostate […]| Newsroom
About twice as many men were diagnosed in 2022 compared to 2001 The post Increasing cases of malignant brain tumors among Swedish men appeared first on Radiationprotection.| Radiationprotection
The breakthrough by UF Health Cancer Center researchers now will be tested in a Phase 1 pediatric clinical trial for brain cancer.| cancer.ufl.edu